Clinical Trials Directory

Trials / Completed

CompletedNCT01872286

Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2

A Double-center Randomized Head-to-head Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
53 (actual)
Sponsor
Changhai Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Capsule endoscopy has been shown to be the first-line endoscopic procedure for small bowel disease. This study was aimed to compare the performance between the frequency-altering AKE-1 capsule and the Pillcam SB2 in patients with suspected small bowel disease.

Conditions

Interventions

TypeNameDescription
DEVICEAKE-1
DEVICEPillcam SB2

Timeline

Start date
2011-11-01
Primary completion
2012-12-01
Completion
2013-02-01
First posted
2013-06-07
Last updated
2014-03-03

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT01872286. Inclusion in this directory is not an endorsement.

Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2 (NCT01872286) · Clinical Trials Directory